Concepedia

K. Richter

KR

17

Publications

1.2K

Citations

14

H-Index

1986

Active since

Affiliations

Pfizer (United States)(Current)

Biogen (United States)

Max Planck Institute of Psychiatry

K. Richter is an author at Pfizer (United States) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1986–2019

17

Publications

17

Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia

Emmanuel Planel, K. Richter, Charles E. Nolan et al. · Journal of Neuroscience · 2007 · 386 citations · Full text

Concentration-Dependent Modulation of Amyloid-β in Vivo and in Vitro Using the γ-Secretase Inhibitor, LY-450139

Thomas A. Lanz, Michael J. Karmilowicz, Kathleen M. Wood et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 133 citations

Glutamate-induced vocalization in the squirrel monkey

Uwe Jürgens, K. Richter · Brain Research · 1986 · 92 citations

, , +8

Discovery of a Highly Selective Glycogen Synthase Kinase‐3 Inhibitor (PF‐04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET Neuroimaging

Steven H. Liang, Jinshan Michael Chen, Marc D. Normandin et al. · Angewandte Chemie International Edition · 2016 · 90 citations · Full text

Conantokin-G: A novel peptide antagonist to the acid (NMDA) receptor

E. Edward Mena, Mary F. Gullak, Martin J. Pagnozzi et al. · Neuroscience Letters · 1990 · 88 citations

, , +6

Rows per page

1–5 of 17